Cargando…
Administration of Human MSC-Derived Extracellular Vesicles for the Treatment of Primary Sclerosing Cholangitis: Preclinical Data in MDR2 Knockout Mice
Primary Sclerosing Cholangitis (PSC) is a progressive liver disease for which there is no effective medical therapy. PSC belongs to the family of immune-mediated biliary disorders and it is characterized by persistent biliary inflammation and fibrosis. Here, we explored the possibility of using extr...
Autores principales: | Angioni, Roberta, Calì, Bianca, Vigneswara, Vasanthy, Crescenzi, Marika, Merino, Ana, Sánchez-Rodríguez, Ricardo, Liboni, Cristina, Hoogduijn, Martin J., Newsome, Philip Noel, Muraca, Maurizio, Russo, Francesco Paolo, Viola, Antonella |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7700340/ https://www.ncbi.nlm.nih.gov/pubmed/33238629 http://dx.doi.org/10.3390/ijms21228874 |
Ejemplares similares
-
Secondary sclerosing cholangitis: mimics of primary sclerosing cholangitis
por: Ludwig, Daniel R., et al.
Publicado: (2022) -
IgG4-Related Sclerosing Cholangitis and Primary Sclerosing Cholangitis
por: Tanaka, Atsushi
Publicado: (2019) -
Primary sclerosing cholangitis.
por: Spence, R. A., et al.
Publicado: (1984) -
Primary sclerosing cholangitis
por: Worthington, Joy, et al.
Publicado: (2006) -
Knockdown of vimentin reduces mesenchymal phenotype of cholangiocytes in the Mdr2(−/−) mouse model of primary sclerosing cholangitis (PSC)
por: Zhou, Tianhao, et al.
Publicado: (2019)